BioSpace News Archive

Olema Pharmaceuticals, Inc. reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a business update.

West Pharmaceutical Services, Inc. announced Eric M. Green, President and CEO, will assume the additional responsibility of Chair of the Company’s Board of Directors, effective as of West’s next Annual Shareholders’ Meeting, which is expected to be May 24, 2022.

DURECT Corporation announced that it will report its fourth quarter and full year 2021 financial results and host a conference call after the market close on Monday, March 7, 2022.

Cosmos Holdings, Inc. announced the closing of a private placement offering to certain institutional investors and an insider of the Company to purchase 6,000 shares of Series A Convertible Preferred Stock and warrants to purchase 2,000,000 shares of common stock.

Terumo Corporation announced that it has established a global “DE&I Philosophy” to further cultivate the culture of Diversity, Equity, and Inclusion at the Terumo Group.

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, presented a late breaking poster recapping positive topline data from a Phase 1 pharmacokinetic study of AQST-109 epinephrine oral film at the American Academy of Allergy, Asthma, and Immunology (AAAAI) annual meeting.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved CARVYKTI™.

GC Pharma announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration in response to its Biologics License Application for ‘GC5107’.